Fuzhou Hanli Biomedical Technology Co., Ltd.

A single-center, open, parallel, uncontrolled, single-cycle, single-dose and multiple-dose vaginal administration test method was used to observe the time course of blood drug concentration of DX01 in healthy female subjects after administration. The pharmacokinetic process of absorption, distribution, metabolism and excretion of DX01 in Chinese people was evaluated to provide clinical basis for the drug registration and production and marketing of DX01.

A multicenter, randomized, blinded, positive drug parallel controlled clinical trial to evaluate the efficacy and safety of DX01 in the treatment of Trichomonas vaginitis and bacterial vaginosis using metronidazole suppositories as a control